Trial intelligence / Profile preview

Heliox in Experimental Upper Airway Obstruction

NCT00788788Phase 2Completed

Sponsor
University of Witten/Herdecke
Start
Nov 2007
Primary completion
Dec 2007
Modality
GAS (Genetic analysis systems)
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of heliox in Airway obstruction (3 arms), sponsored by University of Witten/Herdecke. Primary endpoints: Dyspnea score and Variability of systolic blood pressure. Started Nov 2007; status: completed.

02

Drugs

heliox
03

Conditions

Airway obstruction

Beyond the preview

Go deeper on NCT00788788.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00788788.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call